Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8843221rdf:typepubmed:Citationlld:pubmed
pubmed-article:8843221lifeskim:mentionsumls-concept:C0021051lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0010415lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0010414lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0010416lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0003308lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0031082lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:8843221lifeskim:mentionsumls-concept:C1827061lld:lifeskim
pubmed-article:8843221pubmed:issue4lld:pubmed
pubmed-article:8843221pubmed:dateCreated1996-11-7lld:pubmed
pubmed-article:8843221pubmed:abstractTextSerial isolates of Cryptococcus neoformans from 33 human immunodeficiency virus-infected patients with cryptococcosis were analyzed to determine whether persistence might result from reinfection with a new cryptococcal strain or acquisition of antifungal resistance. Isolates were subtyped by multilocus enzyme electrophoresis (MEE), electrophoretic karyotyping (EK), random-amplified polymorphic DNA (RAPD), and the CNRE-1 DNA probe, MICs of amphotericin B, fluconazole, and 5-fluorocytosine were determined. No changes in MEE or RAPD subtypes were detected in serial isolates from any patient. Isolates from 8 patients (24%) showed alterations in EK only (mobility change in two or more bands) but not with any other subtyping method. MICs did not change significantly in isolates from 30 patients. In 1 case, the fluconazole MIC increased stepwise over 18 months, suggesting development of resistance. These overall invariant subtyping and MIC results confirm previous studies suggesting that persistent cryptococcal infection is due to relapse rather than reinfection or antifungal drug resistance.lld:pubmed
pubmed-article:8843221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843221pubmed:languageenglld:pubmed
pubmed-article:8843221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843221pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8843221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843221pubmed:statusMEDLINElld:pubmed
pubmed-article:8843221pubmed:monthOctlld:pubmed
pubmed-article:8843221pubmed:issn0022-1899lld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:ReesJJlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:MayerL WLWlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:PfallerM AMAlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:BrandtM EMElld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:SpitzerE DEDlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:PinnerR WRWlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:GraviteE PEPlld:pubmed
pubmed-article:8843221pubmed:authorpubmed-author:HajjehR ARAlld:pubmed
pubmed-article:8843221pubmed:issnTypePrintlld:pubmed
pubmed-article:8843221pubmed:volume174lld:pubmed
pubmed-article:8843221pubmed:ownerNLMlld:pubmed
pubmed-article:8843221pubmed:authorsCompleteYlld:pubmed
pubmed-article:8843221pubmed:pagination812-20lld:pubmed
pubmed-article:8843221pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:meshHeadingpubmed-meshheading:8843221-...lld:pubmed
pubmed-article:8843221pubmed:year1996lld:pubmed
pubmed-article:8843221pubmed:articleTitleMolecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.lld:pubmed
pubmed-article:8843221pubmed:affiliationEmerging Bacterial and Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.lld:pubmed
pubmed-article:8843221pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8843221pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843221lld:pubmed